Here is your translated HTML: ```
The ASOBAL League collaborates for the second year with the National Prostate Cancer Association (ANCAP) within the framework of the 'Movember' movement, reaffirming its active support in the fight against prostate cancer, the disease with the highest incidence among the male population of our country. As a result of a link between entities that began to work from the previous season, the elite of Spanish male handball and its clubs, committed to the cause, will focus their media spotlight in the coming weeks on the incidence of the disease and the importance of research and early diagnosis through different actions.
The campaign will focus its loudspeaker on the 2.0 level, weaving an actively informative and educational story within the top-level sports field, which will feature players from all the teams that make up the Plenitude League through their different communication channels. ASOBAL will continue to work in the future to expand synergies with ANCAP, linked to internationally prestigious entities such as Astellas Pharma, Bayer AG, IPSEN Pharma, Pfizer, AstraZeneca, Johnson & Johnson or Novartis, among others.
The role of ANCAP
ANCAP leads the work to make visible and minimize the figures of those affected by prostate cancer in Spain, being the Spanish reference entity that brings together patients, families, health workers and researchers, focusing on the scenario of early diagnosis.
Its action program also has a protocol for advice and accompaniment to those affected by the tumor from twelve lines of action, such as improving the quality of life of the person in treatment, making known the latest techniques to reverse the situation or transmitting the most essential information from talks or training courses.
